Grant: Operating Grant - Priority Announcement: Aging (Bridge Funding)
University of Toronto
$100,000.00
Modulation of the CNS immune status is necessary for full recovery from Alzheimer's disease.
FY 2008-09
Summary
Amyloid disorders, such as Alzheimer's disease and vascular dementia, are characterized by loss of CNS homeostasis and neurodegeneration leading to cognitive decline. The common and central feature of these diseases is amyloid deposition, of which the major component is the amyloid beta peptide (Abeta). To improve treatment of patients and thereby decrease the associated mortality and morbidity, we propose that only early and prolonged treatment with multiple therapeutic strategies will be effective. One component of a multi-drug approach is to re-balance the immunological status of the CNS to promote homeostasis and decrease secondary injury. Using an in vivo model, we will examine the physiological outcome of antagonizing inflammation within the brain to determine the extent of cognitive improvements. Our preliminary results suggest that both parenchymal and perivascular amyloid contribute to disease pathogenesis and only by addressing both will we improve the lives of afflicted individuals.
Department
Program
Operating Grant - Priority Announcement: Aging (Bridge Funding)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
176208
Name
Mclaurin Joanne
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Aging
Theme2
Biomedical
Prcname2
Cell Biology & Mechanisms of Disease
Projecttitle
Modulation of the CNS immune status is necessary for full recovery from Alzheimer's disease.
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Aging (Bridge Funding)
Keyworddelim
Alzheimer'S Disease; Amyloid; Cognition; Inflammation; Macrophage
Abstract
Amyloid disorders, such as Alzheimer's disease and vascular dementia, are characterized by loss of CNS homeostasis and neurodegeneration leading to cognitive decline. The common and central feature of these diseases is amyloid deposition, of which the major component is the amyloid beta peptide (Abeta). To improve treatment of patients and thereby decrease the associated mortality and morbidity, we propose that only early and prolonged treatment with multiple therapeutic strategies will be effective. One component of a multi-drug approach is to re-balance the immunological status of the CNS to promote homeostasis and decrease secondary injury. Using an in vivo model, we will examine the physiological outcome of antagonizing inflammation within the brain to determine the extent of cognitive improvements. Our preliminary results suggest that both parenchymal and perivascular amyloid contribute to disease pathogenesis and only by addressing both will we improve the lives of afflicted individuals.
Competitiondate
200809
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mclaurin, Joanne
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~